Andrew J. Gawron
No Rating Available
(Learn About Our Rating System)

Andrew J. Gawron, MD, PhD

Languages spoken: English

Clinical Locations

Primary Location

Veterans Administration Medical Center

500 S Foothill Blvd
Salt Lake City , UT 84148
801-584-1236
Get Directions

University of Utah Hospital

Gastroenterology Endoscopy Center
50 N Medical Dr
Salt Lake City , UT 84132
801-213-9797
Get Directions

  • Dr. Andrew Gawron is an Associate Professor at the University of Utah and VA Medical Center. His clinical interests include treating patients with esophageal disease (gastroesophageal reflux disease, motility disorders such as achalasia, and eosinophilic esophagitis). He performs colonoscopy, upper endoscopy and interprets esophageal motility and pH studies.


    Dr. Gawron completed his medical degree, internal medicine residency, and gastroenterology fellowship as chief fellow at Northwestern University in Chicago, IL. He received additional experience in diagnosing and treating esophageal disorders at Northwestern University where he served as a Clinical Instructor.
    Dr. Gawron is board certified in Internal Medicine and Gastroenterology. He is a member of the American College of Gastroenterology, the American Gastroenterological Association, the American Society for Gastrointestinal Endoscopy, and the International Society for Diseases of the Esophagus.

    Specialties

    Board Certification

    American Board of Internal Medicine (Sub: Gastroenterology)

  • Dr. Andrew Gawron is an Associate Professor at the University of Utah and VA Medical Center. His clinical interests include treating patients with esophageal disease (gastroesophageal reflux disease, motility disorders such as achalasia, and eosinophilic esophagitis). He performs colonoscopy, upper endoscopy and interprets esophageal motility and pH studies.


    Dr. Gawron completed his medical degree, internal medicine residency, and gastroenterology fellowship as chief fellow at Northwestern University in Chicago, IL. He received additional experience in diagnosing and treating esophageal disorders at Northwestern University where he served as a Clinical Instructor.
    Dr. Gawron is board certified in Internal Medicine and Gastroenterology. He is a member of the American College of Gastroenterology, the American Gastroenterological Association, the American Society for Gastrointestinal Endoscopy, and the International Society for Diseases of the Esophagus.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Professor (Clinical)
    Academic Divisions Gastroenterology
    Board Certification
    American Board of Internal Medicine (Sub: Gastroenterology)

    Education history

    Undergraduate Chemistry, English minor - Truman State University B.S.
    Graduate Training Pharmaceutical Chemistry - University of Kansas M.S.
    Doctoral Training Pharmaceutical Chemistry - University of Kansas Ph.D.
    Research Fellow University of Nebraska Medical Center Postdoctoral Research Fellow
    Professional Medical Medicine - Northwestern University Feinberg School of Medicine M.D.
    Residency Internal Medicine - McGaw Medical Center Resident
    Fellowship Gastroenterology, Hepatology, and Nutrition - McGaw Medical Center Fellow
    Graduate Training Health Services and Outcomes Research - Northwestern University Feinberg School of Medicine M.S.
    Research Fellow Northwestern University Postdoctoral Research Fellow
    Fellowship Northwestern University Feinberg School of Medicine Chief Fellow
    Other Training Leadership & Business - Stanford Graduate School of Business Certificate

    Selected Publications

    Journal Article

    1. Shah SC, Gawron AJ, Li (2020). Surveillance of Gastric Intestinal Metaplasia. The American journal of gastroenterology, 115(5), 641-644. (Read full publication)
    2. DeLay K, Pandolfino JE, Gyawali CP, Frye J, Kaizer A, Menard-Katcher P, Sloan JA, Gawron AJ, Peterson K, Carlson DA, Khan A, Keswani RN, Yadlapati (2020). Esophageal Manometry Competency Program Improves Gastroenterology Fellow Performance in Motility Interpretation. The American journal of gastroenterology, 115(9), 1453-1459. (Read full publication)
    3. Gawron AJ, Yao Y, Gupta S, Cole G, Whooley MA, Dominitz JA, Kaltenbach (2021). Simplifying Measurement of Adenoma Detection Rates for Colonoscopy. Digestive diseases and sciences, 66(9), 3149-3155. (Read full publication)
    4. Gawron AJ, Staub J, Bielefeldt (2021). Impact of Health Insurance, Poverty, and Comorbidities on Colorectal Cancer Screening: Insights from the Medical Expenditure Panel Survey. Digestive diseases and sciences, 66(1), 70-77. (Read full publication)
    5. Altayar O, Davitkov P, Shah SC, Gawron AJ, Morgan DR, Turner K, Mustafa R (2020). AGA Technical Review on Gastric Intestinal Metaplasia-Epidemiology and Risk Factors. Gastroenterology, 158(3), 732-744.e16. (Read full publication)
    6. Low EE, Demb J, Liu L, Earles A, Bustamante R, Williams CD, Provenzale D, Kaltenbach T, Gawron AJ, Martinez ME, Gupta (2020). Risk Factors for Early-Onset Colorectal Cancer. Gastroenterology, 159(2), 492-501.e7. (Read full publication)
    7. Davitkov P, Altayar O, Shah SC, Gawron AJ, Mustafa RA, Sultan S, Morgan D (2020). Advancing the Science in Gastric Pre-Neoplasia: Study Design Considerations. Gastroenterology, 158(3), 751-759. (Read full publication)
    8. Shah SC, Gawron AJ, Mustafa RA, Piazuelo M (2020). Histologic Subtyping of Gastric Intestinal Metaplasia: Overview and Considerations for Clinical Practice. Gastroenterology, 158(3), 745-750. (Read full publication)
    9. Shah SC, Gupta S, Li D, Morgan D, Mustafa RA, Gawron A (2020). Spotlight: Gastric Intestinal Metaplasia. Gastroenterology, 158(3), 704. (Read full publication)
    10. Gawron AJ, Kaltenbach T, Dominitz J (2020). The Impact of the Coronavirus Disease-19 Pandemic on Access to Endoscopy Procedures in the VA Healthcare System. Gastroenterology, 159(4), 1216-1220.e1. (Read full publication)
    11. Gawron AJ, Bell R, Abu Dayyeh BK, Buckley FP, Chang K, Dunst CM, Edmundowicz SA, Jobe B, Lipham JC, Lister D, Canto MI, Smith MS, Starpoli AA, Triadafilopoulos G, Watson TJ, Wilson E, Pandolfino JE, Kaizer A, Van De Voorde Z, Yadlapati (2020). Surgical and endoscopic management options for patients with GERD based on proton pump inhibitor symptom response: recommendations from an expert U.S. panel. Gastrointestinal endoscopy, 92(1), 78-87.e2. (Read full publication)
    12. McKenzie P, Fang J, Davis J, Qiu Y, Zhang Y, Adler DG, Gawron A (2021). Safety of endoscopist-directed nurse-administered balanced propofol sedation in patients with severe systemic disease (ASA class III). Gastrointestinal endoscopy, 94(1), 124-130. (Read full publication)
    13. Bustamante R, Earles A, Murphy JD, Bryant AK, Patterson OV, Gawron AJ, Kaltenbach T, Whooley MA, Fisher DA, Saini SD, Gupta S, Liu (2019). Ascertainment of Aspirin Exposure Using Structured and Unstructured Large-scale Electronic Health Record Data. Medical care, 57(10), e60-e64. (Read full publication)
    14. Keswani RN, Kahi CJ, Benson M, Gawron AJ, Kaltenbach TR, Yadlapati RH, Gregory DL, Duloy (2021). Cecal retroflexion is infrequently performed in routine practice and the retroflexed view is of poor quality. BMC gastroenterology, 21(1), 307. (Read full publication)
    15. Keswani RN, Benson M, Beveridge C, Gawron AJ, Gluskin AB, Kahi CJ, Kaltenbach TR, McClure J, Schenck R, Yadlapati RH, Duloy (2020). Colonoscopy-Naïve Raters Can Be Trained to Assess Colonoscopy Quality. Clinical gastroenterology and hepatology, 18(4), 989-991.e1. (Read full publication)
    16. Demb J, Yaseyyedi A, Liu L, Bustamante R, Earles A, Ghosh P, Gutkind JS, Gawron AJ, Kaltenbach TR, Martinez ME, Gupta (2019). Metformin Is Associated With Reduced Odds for Colorectal Cancer Among Persons With Diabetes. Clinical and translational gastroenterology, 10(11), e00092. (Read full publication)
    17. McVay TR, Garrett G C, Celena B P, Klaus B, Fang JC, Chapman WW, Samore MH, Gawron A (2019). Natural Language Processing Accurately Identifies Dysphagia Indications for Esophagogastroduodenoscopy Procedures in a Large US Integrated Healthcare System: Implications for Classifying Overuse and Quality Measurement. AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science, 2019, 665-671. (Read full publication)
    18. Gawron AJ, Lawrence P, Millar MM, Dominitz JA, Gupta S, Whooley M, Kaltenbach (2018). A Nationwide Survey and Needs Assessment of Colonoscopy Quality Assurance Programs in the VA. Federal practitioner, 35(3), 26-32. (Read full publication)
    19. Gawron A, Bielefeldt (2019). Unrelated Death After Colorectal Cancer Screening: Implications for Improving Colonoscopy Referrals. Federal practitioner, 36(6), 262-270. (Read full publication)
    20. Gawron AJ, Pandolfino JE, Howden C (2014). Initial proton pump inhibitor prescription characteristics associated with long-term use in US Veterans diagnosed with gastroesophageal reflux disease. Journal of pharmaceutical health services research, 5(3), 157-164.
    21. Patel J, Fang J, Taylor LJ, Adler DG, Gawron A (2019). Safety and efficacy of non-anesthesiologist administration of propofol sedation during esophagogastroduodenoscopy in the intensive care unit. Endoscopy international open, 7(4), E625-E629. (Read full publication)
    22. Balbale S, Gawron A, LaVela S (2018). Perceptions of patient-centered care among Veterans with gastroesophageal reflux disease on proton pump inhibitor therapy. Patient experience journal, 5(3), 149-159. (Read full publication)
    23. Earles A, Liu L, Bustamante R, Coke P, Lynch J, Messer K, Martínez ME, Murphy JD, Williams CD, Fisher DA, Provenzale DT, Gawron AJ, Kaltenbach T, Gupta (2018). Structured Approach for Evaluating Strategies for Cancer Ascertainment Using Large-Scale Electronic Health Record Data. JCO clinical cancer informatics, 2, 1-12. (Read full publication)
    24. Keswani RN, Wood M, Benson M, Gawron AJ, Kahi C, Kaltenbach T, Yadlapati R, Gregory D, Duloy (2022). Individualized feedback on colonoscopy skills improves group colonoscopy quality in providers with lower adenoma detection rates. Endoscopy international open, 10(3), E232-E237. (Read full publication)
    25. Gawron AJ, Sultan S, Glorioso TJ, Califano S, Kralovic SM, Jones M, Kirsh S, Dominitz J (2022). Pre-Endoscopy COVID-19 screening and SARS-CoV-2 nucleic acid amplification testing in the VA Healthcare System: Clinical practice patterns, outcomes, and relationship to procedure volume. Gastrointestinal endoscopy, 96(3), 423-432.e7. (Read full publication)
    26. Yadlapati R, Gawron AJ, Gyawali CP, Chen J, Clarke J, Fass R, Jain A, Lynch K, Khan A, Katz PO, Katzka DA, Richter J, Schnoll-Sussman F, Spechler SJ, Vaezi MF, Vela M, Pandolfino J (2022). Clinical role of ambulatory reflux monitoring in PPI non-responders: Recommendation statements. Alimentary pharmacology & therapeutics, (Read full publication)
    27. Gawron AJ, Sultan S, Glorioso TJ, Califano S, Kralovic SM, Jones M, Kirsh S, Dominitz J (2022). Pre-endoscopy coronavirus disease 2019 screening and severe acute respiratory syndrome coronavirus-2 nucleic acid amplification testing in the Veterans Affairs healthcare system: clinical practice patterns, outcomes, and relationship to procedure volume. Gastrointestinal endoscopy, 96(3), 423-432.e7. (Read full publication)
    28. Parbhu SK, Shah SC, Sossenheimer MJ, Fang JC, Peterson KA, Gawron A (2022). Index diagnoses of gastric intestinal metaplasia in the United States: patient characteristics, endoscopic findings, and clinical practice patterns at a large tertiary care center. Therapeutic advances in gastroenterology, 15, 17562848221117640. (Read full publication)
    29. Demb J, Liu L, Bustamante R, Dominitz JA, Earles A, Shah SC, Gawron AJ, Martinez ME, Gupta (2022). COVID-19 Pandemic Had Minimal Impact on Colonoscopy Completion After Colorectal Cancer Red Flag Sign or Symptoms in US Veterans. Digestive diseases and sciences, (Read full publication)
    30. Trivedi M, Godil S, Demb J, Earles A, Bustamante R, Patterson OV, Gawron A, Kaltenbach T, Mahata S, Liu L, Gupta (2022). Baseline characteristics and longitudinal outcomes of traditional serrated adenomas: a cohort study. Clinical gastroenterology and hepatology, (Read full publication)
    31. Gupta S, Earles A, Bustamante R, Patterson OV, Gawron AJ, Kaltenbach TR, Yassin H, Lamm M, Shah SC, Saini SD, Fisher DA, Martinez ME, Messer K, Demb J, Liu (2022). Adenoma Detection Rate and Clinical Characteristics Influence Advanced Neoplasia Risk After Colorectal Polypectomy. Clinical gastroenterology and hepatology, (Read full publication)
    32. Trivedi M, Godil S, Demb J, Earles A, Bustamante R, Patterson OV, Gawron A, Kaltenbach T, Mahata S, Liu L, Gupta (2022). Baseline Characteristics and Longitudinal Outcomes of Traditional Serrated Adenomas: A Cohort Study. Clinical gastroenterology and hepatology, (Read full publication)
    33. Joo YY, Pacheco JA, Thompson WK, Rasmussen-Torvik LJ, Rasmussen LV, Lin FTJ, Andrade M, Borthwick KM, Bottinger E, Cagan A, Carrell DS, Denny JC, Ellis SB, Gottesman O, Linneman JG, Pathak J, Peissig PL, Shang N, Tromp G, Veerappan A, Smith ME, Chisholm RL, Gawron AJ, Hayes MG, Kho A (2023). Multi-ancestry genome- and phenome-wide association studies of diverticular disease in electronic health records with natural language processing enriched phenotyping algorithm. PloS one, 18(5), e0283553. (Read full publication)
    34. Benson R, Winterton C, Winn M, Krick B, Liu M, Abu-El-Rub N, Conway M, Del Fiol G, Gawron A, Hardikar (2023). Leveraging Natural Language Processing to Extract Features of Colorectal Polyps From Pathology Reports for Epidemiologic Study. JCO clinical cancer informatics, 7, e2200131. (Read full publication)
    35. Kaltenbach T, Gawron A, Meyer CS, Gupta S, Shergill A, Dominitz JA, Soetikno RM, Nguyen-Vu T, A Whooley M, Kahi C (2021). Adenoma Detection Rate (ADR) Irrespective of Indication Is Comparable to Screening ADR: Implications for Quality Monitoring. Clinical gastroenterology and hepatology, 19(9), 1883-1889.e1. (Read full publication)
    36. Robertson DJ, Dominitz JA, Beed A, Boardman KD, Del Curto BJ, Guarino PD, Imperiale TF, LaCasse A, Larson MF, Gupta S, Lieberman D, Planeta B, Shaukat A, Sultan S, Menees SB, Saini SD, Schoenfeld P, Goebel S, von Rosenvinge EC, Baffy G, Halasz I, Pedrosa MC, Kahng LS, Cassim R, Greer KB, Kinnard MF, Bhatt DB, Dunbar KB, Harford WV Jr, Mengshol JA, Olson JE, Patel SG, Antaki F, Fisher DA, Sullivan BA, Lenza C, Prajapati DN, Wong H, Beyth R, Lieb JG 2nd, Manlolo J, Ona FV, Cole RA, Khalaf N, Kahi CJ, Kohli DR, Rai T, Sharma P, Anastasiou J, Hagedorn C, Fernando RS, Jackson CS, Jamal MM, Lee RH, Merchant F, May FP, Pisegna JR, Omer E, Parajuli D, Said A, Nguyen TD, Tombazzi CR, Feldman PA, Jacob L, Koppelman RN, Lehenbauer KP, Desai DS, Madhoun MF, Tierney WM, Ho MQ, Hockman HJ, Lopez C, Carter Paulson E, Tobi M, Pinillos HL, Young M, Ho NC, Mascarenhas R, Promrat K, Mutha PR, Pandak WM Jr, Shah T, Schubert M, Pancotto FS, Gawron AJ, Underwood AE, Ho SB, Magno-Pagatzaurtundua P, Toro DH, Beymer CH, Kaz AM, Elwing J, Gill JA, Goldsmith SF, Yao MD, Protiva P, Pohl H, Kyriakides T, CONFIRM Study Grou (2023). Baseline Features and Reasons for Nonparticipation in the Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) Study, a Colorectal Cancer Screening Trial. JAMA network open, 6(7), e2321730. (Read full publication)
    37. Toy G, Colletier K, Hale G, Valentine J, Gawron AJ, Sossenheimer M, Peterson K, Aparicio R, Fang J (2023). Incidence of retained biopsy specimens after esophagogastroduodenoscopy and colonoscopy. Endoscopy international open, 11(7), E653-E659. (Read full publication)
    38. Derek P, Jessica J, Brian S, Shoabo P, Wei C, Jorge R, Andrew G, Joshua B, Jeffrey C, Vicki S, David W, Jessica (2020). P022¿Utilization Patterns of Infliximab Originator to Infliximab Biosimilar in US Veterans. The American journal of gastroenterology, 115(Suppl 1), S6. (Read full publication)
    39. Shah I, Gawron AJ, Byrne KR, Inadomi J (2024). Disparities in Colorectal Cancer Screening Among Asian American Populations and Strategies to Address These Disparities. Gastroenterology, 166(4), 549-552. (Read full publication)
    40. von Rosenvinge EC, Vela SA, Paine ER, Chang MF, Hanson BJ, Taddei T, Smalley WE, Dunbar KB, Khan NH, Kahng LS, Anwar J, Zing R, Gawron A, Dominitz JA, Baffy (2024). A Crisis in Scope: Recruitment and Retention Challenges Reported by VA Gastroenterology Section Chiefs. Federal practitioner, 41(8), 256-260. (Read full publication)
    41. Patel S, Walsh J, Pinnell D, Pei S, Chen W, Rojas J, Rathod A, Johnson J, Gawron A, Curtis JR, Baker JF, Cannon GW, Wu D, Lai M, Sauer B (2024). Real-world experience with biosimilar infliximab-adba and infliximab-dyyb among infliximab-naïve patients with inflammatory bowel disease in the Veterans Health Administration. Medicine, 103(37), e39476. (Read full publication)
    42. Gawron AJ, Bailey T, Codden R, Dominitz J, Gupta S, Helfrich C, Kahi C, Krop L, Malvar C, McKee G, Millar M, Mog A, Nguyen-Vu T, Patterson O, Presson AP, Saini S, Whooley M, Yao Y, Zickmund S, Kaltenbach (2024). Improving colonoscopy quality in the national VA healthcare system. Contemporary clinical trials, 149, 107784. (Read full publication)
    43. Gawron AJ, Mckee G, Dominitz JA, Yao Y, Whooley M, Kaltenbach (2025). Validation of a National Pathology Database for Colonoscopy Quality Reporting and Assurance. Clinical gastroenterology and hepatology, 23(5), 866-868.e1. (Read full publication)
    44. Hanson BJ, Chang MF, Dunbar KB, Khan NH, Taddei T, Smalley WE, Vela SA, Von Rosenvinge EC, Baffy G, Gawron A, Dominitz JA, Paine E (2025). Why VA GI?. Digestive diseases and sciences, (Read full publication)
    45. Kaltenbach T, Martin L, Yu J, Brooke B, Peche W, Soetikno R, Whooley M, Gawron A (2025). Elective colectomy for treatment of benign colon polyps: National surgical trends, outcomes, and cost analysis. Endoscopy international open, 13, a26895839. (Read full publication)
    46. Giera A, Markianos K, Gawron AJ, VA Million Veteran Program, Gupta S, Pyarajan S, Karnam P, Liu L, Shah S (2025). Leveraging Natural Language Processing to Accurately Identify Histologically Confirmed Esophageal and Gastric Premalignant and Malignant Conditions Using a Large-Scale Health-Record Linked Genomic Biobank. Gastro hep advances, 5(1), 100768. (Read full publication)
    47. Gupta S, Demb J, Qin J, Earles A, Lamm M, Doubeni C, Martinez ME, Kaltenbach TR, Gawron AJ, Shah SC, Messer K, Liu (2025). Impact of guideline-concordant post-polypectomy colonoscopy surveillance on colorectal cancer incidence and mortality. Clinical gastroenterology and hepatology, (Read full publication)

    Review

    1. Gawron AJ, Shah SC, Altayar O, Davitkov P, Morgan D, Turner K, Mustafa R (2020). AGA Technical Review on Gastric Intestinal Metaplasia-Natural History and Clinical Outcomes. Gastroenterology, 158(3), 705-731.e5. (Read full publication)

    Editorial

    1. Yadlapati R, Gawron AJ, Pandolfino J (2022). Editorial: wireless pH-monitoring - is it time to put away the pH-impredance catheters: Authors' response. Alimentary pharmacology & therapeutics, 56(8), 1298-1299. (Read full publication)
    2. Gawron AJ, Dominitz J (2022). Higher Quality Colonoscopy: Worth the Wait?. Clinical and translational gastroenterology, 13(4), e00471. (Read full publication)
    3. Shah I, Gawron AJ, Byrne KR, Inadomi J (2024). Disparities in Colorectal Cancer Screening Among Asian American Populations and Strategies to Address These Disparities. Clinical gastroenterology and hepatology, 22(4), 679-683. (Read full publication)

  • News & Podcasts

    News

    Podcasts